Go to content
UR Home

Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: results of the prospective randomized RIST trial

URN to cite this document:
DOI to cite this document:
Corbacioglu, Selim
Date of publication of this fulltext: 20 Mar 2023 10:09

Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons